261 related articles for article (PubMed ID: 11839837)
1. CSF evaluation in primary CNS lymphoma patients by PCR of the CDR III IgH genes.
Gleissner B; Siehl J; Korfel A; Reinhardt R; Thiel E
Neurology; 2002 Feb; 58(3):390-6. PubMed ID: 11839837
[TBL] [Abstract][Full Text] [Related]
2. Analysis of immunoglobulin H gene rearrangement by polymerase chain reaction in primary central nervous system lymphoma.
Kros JM; Bagdi EK; Zheng P; Hop WC; Driesse MJ; Krenacs L; Dinjens WN
J Neurosurg; 2002 Dec; 97(6):1390-6. PubMed ID: 12507138
[TBL] [Abstract][Full Text] [Related]
3. Meningeal dissemination in primary CNS lymphoma: prospective evaluation of 282 patients.
Fischer L; Martus P; Weller M; Klasen HA; Rohden B; Röth A; Storek B; Hummel M; Nägele T; Thiel E; Korfel A
Neurology; 2008 Sep; 71(14):1102-8. PubMed ID: 18824675
[TBL] [Abstract][Full Text] [Related]
4. Single-cell PCR analysis of the immunoglobulin heavy-chain CDR3 region for the diagnosis of leptomeningeal involvement of B-cell malignancies using standard cerebrospinal fluid cytospins.
Hug A; Storch-Hagenlocher B; Haas J; Vogt-Schaden ME; Goldschmidt H; Wildemann B
J Neurol Sci; 2004 Apr; 219(1-2):83-8. PubMed ID: 15050442
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma.
De Luca A; Antinori A; Cingolani A; Larocca LM; Linzalone A; Ammassari A; Scerrati M; Roselli R; Tamburrini E; Ortona L
Br J Haematol; 1995 Aug; 90(4):844-9. PubMed ID: 7669663
[TBL] [Abstract][Full Text] [Related]
6. Isolated leptomeningeal infiltration of a primary CNS B-cell lymphoma diagnosed by flow cytometry and confirmed by necropsy.
Broussalis E; Hutterer M; Oppermann K; Wipfler P; Pilz G; Harrer A; Haschke-Becher E; Golaszewski S; Schönauer U; Weis S; Killer-Oberpfalzer M; Mc Coy M; Trinka E; Kraus J
Acta Neurol Scand; 2012 Sep; 126(3):e11-6. PubMed ID: 22211863
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial.
Korfel A; Weller M; Martus P; Roth P; Klasen HA; Roeth A; Rauch M; Hertenstein B; Fischer T; Hundsberger T; Leithäuser M; Birnbaum T; Kirchen H; Mergenthaler HG; Schubert J; Berdel W; Birkmann J; Hummel M; Thiel E; Fischer L
Ann Oncol; 2012 Sep; 23(9):2374-2380. PubMed ID: 22396446
[TBL] [Abstract][Full Text] [Related]
8. Spinal primary central nervous system lymphoma: Case report and literature review.
Feng L; Chen D; Zhou H; Shen C; Wang H; Sun X; Liang X; Chen L
J Clin Neurosci; 2018 Apr; 50():16-19. PubMed ID: 29429785
[TBL] [Abstract][Full Text] [Related]
9. Soluble TACI and soluble BCMA as biomarkers in primary central nervous system lymphoma.
Thaler FS; Laurent SA; Huber M; Mulazzani M; Dreyling M; Ködel U; Kümpfel T; Straube A; Meinl E; von Baumgarten L
Neuro Oncol; 2017 Nov; 19(12):1618-1627. PubMed ID: 28521029
[TBL] [Abstract][Full Text] [Related]
10. MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study.
Ferreri AJM; Calimeri T; Lopedote P; Francaviglia I; Daverio R; Iacona C; Belloni C; Steffanoni S; Gulino A; Anghileri E; Diffidenti A; Finardi A; Gagliardi F; Anzalone N; Nonis A; Furlan R; De Lorenzo D; Terreni MR; Martinelli V; Sassone M; Foppoli M; Angelillo P; Guggiari E; Falini A; Mortini P; Filippi M; Tarantino V; Eoli M; Ciceri F; Doglioni C; Tripodo C; Locatelli M; Cangi MG; Ponzoni M
Br J Haematol; 2021 May; 193(3):497-505. PubMed ID: 33620087
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological analysis and specific discriminating markers of interleukin detection in cerebrospinal fluid with primary central nervous system lymphoma: results from a retrospective study.
Li J; Tang X; Luo X; Liu L; Li D; Yang L
Ann Hematol; 2023 Aug; 102(8):2153-2163. PubMed ID: 37289220
[TBL] [Abstract][Full Text] [Related]
12. Limited detection of IgH gene rearrangements in plasma of patients with primary central nervous system lymphoma.
He J; Wu J; Jiao Y; Rodriguez FJ; Blakeley JO; Kinzler KW; Papadopoulos N; Vogelstein B; Holdhoff M
J Neurooncol; 2013 Sep; 114(3):275-9. PubMed ID: 23828278
[TBL] [Abstract][Full Text] [Related]
13. CSF analysis of IgH gene rearrangement in CNS lymphoma: relationship to the disease course.
Ekstein D; Ben-Yehuda D; Slyusarevsky E; Lossos A; Linetsky E; Siegal T
J Neurol Sci; 2006 Aug; 247(1):39-46. PubMed ID: 16678210
[TBL] [Abstract][Full Text] [Related]
14. Meningeal dissemination in primary CNS lymphoma: diagnosis, treatment, and survival in a large monocenter cohort.
Kiewe P; Fischer L; Martus P; Thiel E; Korfel A
Neuro Oncol; 2010 Apr; 12(4):409-17. PubMed ID: 20308318
[TBL] [Abstract][Full Text] [Related]
15. Detection of subclinical systemic disease in primary CNS lymphoma by polymerase chain reaction of the rearranged immunoglobulin heavy-chain genes.
Jahnke K; Hummel M; Korfel A; Burmeister T; Kiewe P; Klasen HA; Müller HH; Stein H; Thiel E
J Clin Oncol; 2006 Oct; 24(29):4754-7. PubMed ID: 16966685
[TBL] [Abstract][Full Text] [Related]
16. The CSF IL-10 concentration is an effective diagnostic marker in immunocompetent primary CNS lymphoma and a potential prognostic biomarker in treatment-responsive patients.
Nguyen-Them L; Costopoulos M; Tanguy ML; Houillier C; Choquet S; Benanni H; Elias-Shamieh R; Armand M; Faivre G; Glaisner S; Malak S; Vargaftig J; Hoang-Xuan K; Ahle G; Touitou V; Cassoux N; Davi F; Merle-Béral H; Le Garff-Tavernier M; Soussain C;
Eur J Cancer; 2016 Jul; 61():69-76. PubMed ID: 27156226
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma.
Bossolasco S; Cinque P; Ponzoni M; Vigano MG; Lazzarin A; Linde A; Falk KI
J Neurovirol; 2002 Oct; 8(5):432-8. PubMed ID: 12402169
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of the CDR3 encoding region of the immunoglobulin heavy chain locus in cerebrospinal fluid cells as a diagnostic tool in lymphomatous meningitis.
Storch-Hagenlocher B; Haas J; Vogt-Schaden ME; Bentz M; Hoffmann LA; Biessmann A; Wildemann B
Ann Neurol; 2000 Feb; 47(2):211-7. PubMed ID: 10665492
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-30c as a novel diagnostic biomarker for primary and secondary B-cell lymphoma of the CNS.
Baraniskin A; Chomiak M; Ahle G; Gress T; Buchholz M; Turewicz M; Eisenacher M; Margold M; Schlegel U; Schmiegel W; Hahn S; Schroers R
J Neurooncol; 2018 May; 137(3):463-468. PubMed ID: 29327175
[TBL] [Abstract][Full Text] [Related]
20. Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for primary central nervous system lymphoma.
Baraniskin A; Zaslavska E; Nöpel-Dünnebacke S; Ahle G; Seidel S; Schlegel U; Schmiegel W; Hahn S; Schroers R
Neuro Oncol; 2016 Mar; 18(3):361-7. PubMed ID: 26250566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]